In this interview, Timothy Garrett (University of Florida, FL, USA) discusses the use of MS in his research, some of the key differences between imaging MS and LC–MS and gives some top tips for method development.
In a Bioanalysis perspective article, Rasa Santockyte (Bristol Myers Squibb, NJ, USA) explored the topic of critical reagents in LBAs and hybrid LC–MS assays. We caught up with Rasa to find out the latest in the field.
Critical reagent screening and characterization: benefits and approaches for protein biomarker assays by hybrid LC–MS
In this perspective article from Bioanalysis, the authors discuss the similarities and differences of critical reagents in LBAs and hybrid LC–MS assays. The authors propose that the benefits of well-characterized hybrid LC–MS assay reagents are frequently underestimated.
Shimadzu (Kyoto, Japan) has announced the release of the LCMS-8060NX, a new liquid chromatograph mass spectrometer. The LCMS-8060NX aims to deliver high levels of sensitivity, detection speeds, ease of use and robustness when preparing and analyzing scientific samples.
Since 2013 the short course teaching best practice for maintaining and troubleshooting LC–MS systems has been delivered at the ASMS conference. Ahead of the virtual ASMS 2020 Reboot, we caught up with the course instructors to see what’s new.
In this interview we caught up with Jian Guo (University of British Columbia, Vancouver, Canada) to discuss his research inspirations, current research focus and what he hopes attendees will gain from his presentation at ASMS 2020 Reboot.
In this Learn with Lin article, Zone Leader Lin Wang (Covance, NJ, USA) explores some of the key terms in LC–MS that form the foundations of a good understanding of the bioanalytical applications of this technique.
Thermo Fisher Scientific (MD, USA) have entered a collaboration with diagnostic platform designer, NanoPin Technologies (AZ, USA), to develop new LC–MS-based workflows to advance the detection technology available for blood-based infectious diseases.
In this interview, Richard Kay (Wellcome Trust, University of Cambridge, UK) discusses his use of HRMS and QQQ for the analysis of the peptidome.
In this interview, Kevork Kalaydjian (ZefSci; QC, Canada) explores the changing perspectives towards cannabis and how bioanalytical scientists can help improve the understanding of the scientific benefits and limitations of cannabis and its derivatives.